Macao Confirms Chikungunya and Dengue Fever Cases

To inform Macao residents about the SAR Government's overall prevention and control strategy and specific implementation measures for Chikungunya and dengue fever as early as possible, the Health Bureau held a press conference today to introduce the current epidemic situation.

As of October 11, 2025, Director Luo Yilong stated in a media release that since the first imported case of Chikungunya in Macao at the end of July, Macao has recorded 32 cases, of which 24 were imported and eight were locally infected by mosquitoes carrying the virus.

Considering the situation in neighboring regions and the flow of people, the risk of importing Chikungunya into Macao continues to exist. However, at present, local cases are still sporadic, and no clusters have occurred.

Medical Director Zeng Tanfei and Attending Physician Tian Yakun introduced the treatment of patients with double fever at the Conde S. Januario Hospital. As of October 12, 2025, there were six patients currently receiving hospitalization for double fever at the Conde S. Januario Hospital, four of whom were diagnosed with Chikungunya and two with dengue fever, none of whom had serious complications.

Macao, an autonomous region on the south coast of China, advises that residents with questions can contact the Health Bureau's infectious disease hotline at 28700800.

Furthermore, the outbreak of Chikungunya in Guangdong Province, China, continues.

To enhance disease awareness in China, the first Chikungunya virus detection product was approved in October 2025 for marketing in the country. It can be used for the in vitro diagnosis of Chikungunya cases. 

As of October 13, 2025, the U.S. CDC includes this area of China in a Travel Health Notice and recommends vaccination for specific travelers ahead of departure.